"Medical students are uniquely positioned to open the door to this discussion about disability and chronic illness," argues Stanford med student Claire Rhee.
A new generation of brain cancer patients are working to improve care and connect and support patients using social media and advocacy.
A new book by Stanford researchersexamines China’s cigarette industry to understand the root causes of our global cigarette epidemic.
Scientists use a tweaked version of CRISPR gene editing to turn skin cells into neurons, and simultaneously identify neuron-specific genes.
A new variation of gene-editing technology CRISPR allows scientists to reorganize DNA in a cell's nucleus in three dimensions, altering cell function.
In the latest installment in the series Understanding AFib, Randall Stafford explains the different types of blood thinners.
Decision scientist Mehlika Toy is working with the WHO to help eliminate the public health burden of hepatitis B by the year 2030.
A network of doctors that aims to diagnose mystery diseases has named 31 newly identified conditions and diagnosed more than 100 previously unsolved cases.
Stanford researchers have learned that cancer cells can batter their way into new territory, rather than relying on dissolving chemicals.
In this Stanford Medicine Unplugged essay, Yoo Jung Kim discusses how she learned that it was okay not to know everything as a medical student.
A new paper outlines strategies to promote gender diversity in research teams, which can also generate new questions, techniques and results.
Digital medicine advances prompt call for more study about potential implications and ethical issues for patients and clinicians.
Stanford's WELL for Life programs challenges participants to spend mindfully, in an effort to understand the relationship between well-being and finances.
At a recent conversation hosted by Dean Lloyd Minor, journalist and entrepreneur Jessica Lessin discusses the state of technology and journalism.
Jim Yong Kim shared insights from his experience at the helm of global health and financing organizations at a recent address on campus.
Cancerous tumors cause disease in two ways: they grow and spread. But a new immune therapy approach may be able to target both problems simultaneously.